These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 35074713)

  • 21. Induced Pluripotent Stem Cell Generation from Blood Cells Using Sendai Virus and Centrifugation.
    Rim YA; Nam Y; Ju JH
    J Vis Exp; 2016 Dec; (118):. PubMed ID: 28060310
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Generation of a human induced pluripotent stem cell (iPSC) line from a 64year old male patient with multiple schwannoma.
    Zhang S; Lv Z; Hu Y; Liu L; Gong W; Li Q; Wu H
    Stem Cell Res; 2017 Mar; 19():49-51. PubMed ID: 28413006
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Generation of three age and gender matched pairs of human induced pluripotent stem cells derived from myoblasts (MDCi011-A, MDCi012-A, MDCi013-A) and from peripheral blood mononuclear cells (MDCi011-B, MDCi012-B, MDCi013-B) from the same donor.
    Metzler E; Telugu N; Diecke S; Spuler S; Escobar H
    Stem Cell Res; 2020 Oct; 48():101987. PubMed ID: 32961449
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Generation of integration-free induced pluripotent stem cell lines from four pediatric ADHD patients.
    Grossmann L; Yde Ohki CM; Döring C; Hoffmann P; Herms S; Werling AM; Walitza S; Grünblatt E
    Stem Cell Res; 2021 May; 53():102268. PubMed ID: 33662736
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Generation and characterization of an induced pluripotent stem cell (iPSC) line from a patient with clozapine-resistant Schizophrenia.
    Marsoner F; Marcatili M; Karnavas T; Bottai D; D'Agostino A; Scarone S; Conti L
    Stem Cell Res; 2016 Nov; 17(3):661-664. PubMed ID: 27934603
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Generation of the induced pluripotent stem cell line UHOMi002-A from peripheral blood mononuclear cells of a healthy male donor.
    Fieldes M; Ahmed E; Bourguignon C; Mianné J; Martin M; Arnould C; Vachier I; Assou S; De Vos J; Bourdin A
    Stem Cell Res; 2020 Dec; 49():102037. PubMed ID: 33099111
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Establishment of Human Induced Pluripotent Stem Cells from Multiple Sclerosis Patients.
    Begentas OC; Koc D; Kiris E
    Methods Mol Biol; 2022; 2549():43-67. PubMed ID: 34988943
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Establishment of induced pluripotent stem cell (iPSC) line from 55-year old male patient with hemorrhagic Moyamoya disease.
    Cardano M; Marsoner F; Marcatili M; Karnavas T; Zasso J; Lanterna LA; Conti L
    Stem Cell Res; 2016 Nov; 17(3):623-626. PubMed ID: 27934594
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Generation of an induced pluripotent stem cell line (DHMCi009-A) from an individual with TUBB2A tubulinopathy.
    Schröter J; Syring H; Göhring G; Kölker S; Opladen T; Hoffmann GF; Syrbe S; Jung-Klawitter S
    Stem Cell Res; 2022 Oct; 64():102879. PubMed ID: 35930870
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Generation of human iPSC line GRX-MCiPS4F-A2 from adult peripheral blood mononuclear cells (PBMCs) with Spanish genetic background.
    Cabrera S; Ji AR; Frejo L; Ramos-Mejia V; Romero T; Real P; Lopez-Escamez JA
    Stem Cell Res; 2015 Sep; 15(2):337-40. PubMed ID: 26284980
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Establishment of a human induced pluripotent stem cell line (TAUi008-A) derived from a multiple sclerosis patient.
    Lotila J; Hyvärinen T; Skottman H; Airas L; Narkilahti S; Hagman S
    Stem Cell Res; 2022 Aug; 63():102865. PubMed ID: 35843021
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Establishment of induced pluripotent stem cell (iPSC) line from an 8-year old female patient with ischemic Moyamoya disease.
    Cardano M; Marsoner F; Zasso J; Marcatili M; Karnavas T; Lanterna LA; Conti L
    Stem Cell Res; 2016 Nov; 17(3):619-622. PubMed ID: 27934593
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Establishment of an induced pluripotent stem cell (iPSC) line from a patient with Clozapine-responder Schizophrenia.
    Marcatili M; Marsoner F; D'Agostino A; Karnavas T; Bottai D; Scarone S; Conti L
    Stem Cell Res; 2016 Nov; 17(3):630-633. PubMed ID: 27934596
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Generation of the UAE's first Emirati induced pluripotent stem cell line KUSTi001-A from peripheral blood derived CD34+ hematopoietic cells.
    Azzam SK; Alsafar H; Sajini AA
    Stem Cell Res; 2022 Aug; 63():102853. PubMed ID: 35816920
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Generation of an induced pluripotent stem cell line (DHMCi008-A) from an individual with TUBA1A tubulinopathy.
    Schröter J; Syring H; Göhring G; Kölker S; Opladen T; Hoffmann GF; Syrbe S; Jung-Klawitter S
    Stem Cell Res; 2022 Jul; 62():102818. PubMed ID: 35636247
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Establishment of a human iPSC line (MUSIi007-A) from peripheral blood of normal individual using Sendai viral vectors.
    Potirat P; Wattanapanitch M; Kheolamai P; Issaragrisil S
    Stem Cell Res; 2018 Oct; 32():43-46. PubMed ID: 30172906
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reprogramming human B cells into induced pluripotent stem cells and its enhancement by C/EBPα.
    Bueno C; Sardina JL; Di Stefano B; Romero-Moya D; Muñoz-López A; Ariza L; Chillón MC; Balanzategui A; Castaño J; Herreros A; Fraga MF; Fernández A; Granada I; Quintana-Bustamante O; Segovia JC; Nishimura K; Ohtaka M; Nakanishi M; Graf T; Menendez P
    Leukemia; 2016 Mar; 30(3):674-82. PubMed ID: 26500142
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development of human induced pluripotent stem cell (iPSC) line from a 60year old female patient with multiple schwannoma.
    Zhang S; Lv Z; Liu Y; Li Q; Gong W; Liu L; Wu H
    Stem Cell Res; 2017 Mar; 19():31-33. PubMed ID: 28413001
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Generation of Human Induced Pluripotent Stem Cells Using RNA-Based Sendai Virus System and Pluripotency Validation of the Resulting Cell Population.
    Chichagova V; Sanchez-Vera I; Armstrong L; Steel D; Lako M
    Methods Mol Biol; 2016; 1353():285-307. PubMed ID: 25697416
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reprogramming Methods Do Not Affect Gene Expression Profile of Human Induced Pluripotent Stem Cells.
    Trevisan M; Desole G; Costanzi G; Lavezzo E; Palù G; Barzon L
    Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28117672
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.